__________________________________________________________________________________________
Re: Global ID / Local ID: TH201409008546/ TH140903035 FU (3)
Thank you for reporting to us an adverse event related to Lilly product(s).
We would like to collect more information to better understanding the reported event.
Please respond to following question regarding the adverse event – Urinary incontinence, involving a female patient, aged 77, who was subscribed Forteo, reported the event to Lilly on 22-Sep-2014.
Please provide the informatoin for following:
1. Which concomitant drugs patient are taking for uric acid and degenerative joint disease?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
2. Did the event of urinary incontinence reappeared after the drugs were rechallenged ( or were the drugs permanently discontinued)?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
3. Date of onset of degenerative joint disease?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
4. Any laboratory investigations?
____________________________________________________________________________
¬¬¬¬
____________________________________________________________________________
____________________________________________________________________________
HCP’s signature:
Date:
__________________________________________________________________________________
For Eli Lilly internal use only
Date of Confirmation of FU request sent to HCP:
Name and Designation: